GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » European Medical Solutions (FRA:AS0) » Definitions » 14-Day RSI

European Medical Solutions (FRA:AS0) 14-Day RSI : 40.54 (As of Jun. 19, 2024)


View and export this data going back to 2021. Start your Free Trial

What is European Medical Solutions 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-06-19), European Medical Solutions's 14-Day RSI is 40.54.

The industry rank for European Medical Solutions's 14-Day RSI or its related term are showing as below:

FRA:AS0's 14-Day RSI is ranked better than
74.36% of 1564 companies
in the Biotechnology industry
Industry Median: 43.815 vs FRA:AS0: 40.54

Competitive Comparison of European Medical Solutions's 14-Day RSI

For the Biotechnology subindustry, European Medical Solutions's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


European Medical Solutions's 14-Day RSI Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, European Medical Solutions's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where European Medical Solutions's 14-Day RSI falls into.



European Medical Solutions  (FRA:AS0) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


European Medical Solutions  (FRA:AS0) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


European Medical Solutions 14-Day RSI Related Terms

Thank you for viewing the detailed overview of European Medical Solutions's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


European Medical Solutions (FRA:AS0) Business Description

Traded in Other Exchanges
Address
7 Rue des Chasseurs Ardennais, Liege, BEL, 4031
DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.

European Medical Solutions (FRA:AS0) Headlines

No Headlines